Judging from the total number of sick people, the pediatric drug market has a large potential market capacity, of which about 85% of children suffer from respiratory diseases and digestive system diseases. Such children account for the highest proportion, and have the characteristics of frequent and repeated disease. Judging from the proportion of the population in each age group in the discharged population in 2012, the proportion of children with intestinal infectious diseases, upper respiratory tract infections, lower respiratory tract infections (pneumonia) and influenza was 65%, 79.7%, 75.5% and 66.9%, respectively. As a well-known pediatric brand, Hailongwa series, as a pediatric drug expert, fully cares about the health of babies!